Literature DB >> 7326827

Specific binding of the tumor promoter TPA in various mouse organs as measured by a "cold acetone-filter assay'.

M Hergenhahn, E Hecker.   

Abstract

Rapid, specific, saturable and partially reversible binding of the tumor promoter 12-O-tetradecanoylphorbol-13-acetate ([3H]TPA) to a particulate fraction of mouse brain can be demonstrated by means of a "cold acetone-filter assay'; by washing with cold acetone at -20 degree C, nonspecific binding of the highly lipophilic [3H]TPA to membranes can be reduced to approximately 10% of the total binding. A comparative study of homogenates of several organs with this test revealed specific [3H]TPA binding/microgram DNA in the order brain much greater than lung approximately equal to spleen approximately equal to liver approximately equal to kidney approximately equal to thymus approximately equal to ovaries. Specific binding sites were also detected in 600 x g supernatant fractions of homogenates from epidermis, forestomach, glandular stomach and small intestine. Competition experiments showed displacement of [3H]TPA by TPA greater than phorbol-12,13-didecanoate greater than 12-deoxyphorbol-13-tetradecanoate greater than phorbol-12,13-dibutyrate (PDBu) greater than phorbol-12,13-diacetate greater than 4-O-methyl-TPA greater than 4 alpha-phorbol-12,13-didecanoate in the brain particulate fraction. Specific [3H]TPA binding is sensitive to heat, periodate and dithiothreitol, but is relatively insensitive to urea or to 1-5% solutions of several common detergents. It is estimated that the present binding test is approximately 500 times more sensitive than the widely-accepted [3H]PDBu assay; perhaps more important, the present method employs TPA, which is extremely effective both as a tumor promoter in vivo and as a pleiotropic effector of cells in vivo and in vitro.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7326827     DOI: 10.1093/carcin/2.12.1277

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  7 in total

1.  Toxicodynamics of tumour promoters of mouse skin. III. Specific binding of the tumour promoter thapsigargin as measured by the cold-acetone filter assay.

Authors:  S B Christensen; M Hergenhahn; H Roeser; E Hecker
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  Thapsigargin, a histamine secretagogue, is a non-12-O-tetradecanoylphorbol-13-acetate (TPA) type tumor promoter in two-stage mouse skin carcinogenesis.

Authors:  H Hakii; H Fujiki; M Suganuma; M Nakayasu; T Tahira; T Sugimura; P J Scheuer; S B Christensen
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

3.  Induction of Epstein-Barr virus early antigens by tumor promoters of the diterpene ester type in Raji cells and specific (receptor) binding as compared to irritant and promoting activities.

Authors:  U Kloz; M Hergenhahn; M Fellhauer; E Hecker
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

4.  Phorbol diester receptor copurifies with protein kinase C.

Authors:  J E Niedel; L J Kuhn; G R Vandenbark
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

5.  Toxicodynamics of tumour promoters of mouse skin. II. Binding to protein kinase C of some new diterpene esters and induction of luminol-enhanced chemoluminescence in mouse peritoneal neutrophils.

Authors:  M Hergenhahn; U Kloz; M Fellhauer; G L Tremp; E Hecker
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

Review 6.  Host defense mechanisms against tumors as the principal targets of tumor promoters.

Authors:  R Keller
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

7.  Effects of diterpene esters of tigliane, daphnane, ingenane, and lathyrane types on pink bollworm,Pectinophora gossypiella saunders (Lepidoptera: Gelechiidae).

Authors:  G T Marshall; J A Klocke; L J Lin; A Douglas Kinghorn
Journal:  J Chem Ecol       Date:  1985-02       Impact factor: 2.626

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.